Docoh
Loading...

RVP Retractable

Filed: 3 Jun 21, 4:21pm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 28, 2021

 

Retractable Technologies, Inc.

 

(Exact name of registrant as specified in its charter)

 

Texas 001-16465 75-2599762
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) 

Identification No.)

 

511 Lobo Lane, Little Elm, Texas 75068-5295
(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number, including area code (972) 294-1010

 

None

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common StockRVPNYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01Entry into a Material Definitive Agreement

 

Effective May 28, 2021, the Company entered into an amendment to the delivery order from the U.S. Department of Health and Human Services which was awarded May 1, 2020. The amendment changes the period of performance end date from May 2021 to March 2022 and reallocates the products ordered to increase shipments of 1mL low dead-space safety syringes. Attached as Exhibit 99.1 is a press release dated June 3, 2021 announcing the amendment.

 

Item 8.01Other Events.

 

On June 1, 2021, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing its receipt of a notice regarding the extension of a government contract.

 

Item 9.01Financial Statements and Exhibits.

 

(d)  Exhibits

 

99.1Press release announcing amendment to delivery order
99.2Press release announcing receipt of notice to extend contract

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DATE: June 3, 2021RETRACTABLE TECHNOLOGIES, INC.
 (Registrant)

 

 BY:/s/ JOHN W. FORT III
  JOHN W. FORT III
  VICE PRESIDENT, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER